Horizon Cancer Mission: Older Patients' Quality of Life
Funds five projects, €5-6M each, that develop and test care approaches built around what cancer patients over 65 actually need during and after treatment.
More than two out of three new cancer diagnoses in Europe are in someone aged 65 or older, and that share keeps growing. Yet most cancer research still treats age as an afterthought: older patients are consistently left out of clinical trials, so treatments, care pathways and even the outcomes researchers measure end up built around younger, healthier patients. This topic funds closing that gap — …
Researching the care needs of cancer patients aged 65 and older, then developing, testing and scaling holistic care approaches and tools — through pragmatic clinical trials or effectiveness-implementation hybrid designs run in real-life care settings, not lab studies — to reduce comorbidities, impairments and frailty and improve quality of life during and after treatment. Work covers quality-of-life assessment across patient cohorts, age-specific treatment and follow-up regimens (including prehabilitation before treatment starts), and care domains from pain management and mental health to rehabilitation and health/digital literacy. Patients, survivors, caregivers and SSH experts have to be directly involved throughout, trial endpoints have to be defined jointly with them, and the resulting evidence has to hold up across the diversity of EU Member States' and Associated Countries' health systems.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up